Clinical trials recruiting for Locally Advanced Colorectal Cancer
3
Recruiting trials
0
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Phase 3 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Pembrolizumab | 2 |
| ADG126 | 1 |
| Bevacizumab | 1 |
| Capecitabine | 1 |
| FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) | 1 |
| Mitomycin (MM) | 1 |
| Oxaliplatin | 1 |
Self-screener
Recruiting trials
- CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer
- Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Advanced Colon Cancer
- Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer
Related conditions
Trials recruiting for Locally Advanced Colorectal Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Locally Advanced Colorectal Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.